​

Aclarion Stock (NASDAQ:ACON)

RevenueOwnershipFinancialsChart
Aclarion by TradingView

Previous Close

$0.11

52W Range

$0.10 - $6.75

50D Avg

$0.17

200D Avg

$0.25

Market Cap

$1.30M

Avg Vol (3M)

$621.41K

Beta

0.40

Div Yield

-

ACON Company Profile

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Apr 22, 2022

Website

ACON Performance

ACON Financial Summary

Dec 23Dec 22Dec 21
Revenue$75.40K$60.44K$60.29K
Operating Income$-4.88M$-6.10M$-2.95M
Net Income$-4.91M$-9.11M$-3.53M
EBITDA$-4.88M$-5.90M$-4.66M
Basic EPS$-8.82$-1.49$-0.49
Diluted EPS$-8.82$-1.49$-0.49

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

TickerCompany
FORAForian Inc.
NRCNational Research Corporation
HCTIHealthcare Triangle, Inc.
MGRXMangoceuticals, Inc.
HSTMHealthStream, Inc.
EUDAEUDA Health Holdings Limited